Items where authors include "Palmer, S."

Number of items: 55.

Article

Tyrer, F., Gharibzadeh, S., Gillies, C. et al. (1306 more authors) (2025) Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study. Diabetes, Obesity and Metabolism: A Journal of Pharmacology and Therapeutics, 27 (2). pp. 767-776. ISSN 1462-8902

Towers, A.M., Rand, S., Allen, S. et al. (12 more authors) (2025) Assessing the feasibility of measuring residents’ quality of life in English care homes and the construct validity and internal consistency of measures completed by staff proxy: a cross-sectional study. BMJ Open, 15 (1). e090684. ISSN 2044-6055

Gordon, A.L., Rand, S., Crellin, E. et al. (19 more authors) (2025) Piloting a minimum data set for older people living in care homes in England: a developmental study. Age and Ageing, 54 (1). afaf001. ISSN 0002-0729

Gharibzadeh, S., Routen, A., Razieh, C. et al. (1382 more authors) (2025) Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study. eClinicalMedicine, 79. 103005. ISSN 2589-5370

Taquet, M., Skorniewska, Z., De Deyn, T. et al. (1085 more authors) (2024) Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK. The Lancet Psychiatry, 11 (9). P696-708. ISSN 2215-0366

Lawson, C.A., Moss, A.J., Arnold, J.R. et al. (1341 more authors) (2024) Long COVID and cardiovascular disease: a prospective cohort study. Open Heart, 11 (1). e002662. ISSN 2053-3624

Liew, F., Efstathiou, C. orcid.org/0000-0001-6125-8126, Fontanella, S. et al. (1457 more authors) (2024) Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease. Nature Immunology, 25 (4). pp. 607-621. ISSN 1529-2908

Elneima, O., McAuley, H.J.C., Leavy, O.C. et al. (1398 more authors) (2024) Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study. International Journal of Epidemiology, 53 (1). dyad165. ISSN 0300-5771

Elneima, O. orcid.org/0000-0003-2480-8840, McAuley, H.J.C. orcid.org/0000-0001-8997-0764, Leavy, O.C. et al. (1398 more authors) (2024) Cohort profile: post-hospitalisation COVID-19 (PHOSP-COVID) study. International Journal of Epidemiology, 53 (1). dyad165. ISSN 0300-5771

Lord, J.M., Veenith, T., Sullivan, J. et al. (1020 more authors) (2024) Accelarated immune ageing is associated with COVID-19 disease severity. Immunity & Ageing, 21. 6. ISSN 1742-4933

Taquet, M., Skorniewska, Z., Zetterberg, H. orcid.org/0000-0003-3930-4354 et al. (1262 more authors) (2023) Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury. Brain Communications, 6 (1). fcad357. ISSN 2632-1297

Rangelov, B. orcid.org/0000-0001-7017-1575, Young, A. orcid.org/0000-0002-7772-781X, Lilaonitkul, W. et al. (145 more authors) (2023) Author Correction: Delineating COVID-19 subgroups using routine clinical data identifies distinct in-hospital outcomes. Scientific Reports, 13. 18376. ISSN 2045-2322

Brightling, C.E., Evans, R.A., Singapuri, A. et al. (1049 more authors) (2023) Long COVID research: an update from the PHOSP-COVID Scientific Summit. The Lancet Respiratory Medicine, 11 (11). e93-e94. ISSN 2213-2600

Raman, B., McCracken, C., Cassar, M.P. et al. (1038 more authors) (2023) Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study. The Lancet Respiratory Medicine, 11 (11). pp. 1003-1019. ISSN 2213-2600

Jackson, C., Stewart, I.D., Plekhanova, T. et al. (1082 more authors) (2023) Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study. The Lancet Respiratory Medicine, 11 (8). pp. 673-684. ISSN 2213-2600

Zheng, B., Vivaldi, G. orcid.org/0000-0003-0816-9276, Daines, L. orcid.org/0000-0003-0564-4000 et al. (1040 more authors) (2023) Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls. The Lancet Regional Health - Europe, 29. 100635. ISSN 2666-7762

Liew, F. orcid.org/0000-0002-8736-9198, Talwar, S., Cross, A. et al. (1439 more authors) (2023) SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination. eBioMedicine, 87. 104402. ISSN 2352-3964

Aggarwal, D. orcid.org/0000-0002-5938-8172, Page, A.J. orcid.org/0000-0001-6919-6062, Schaefer, U. et al. (602 more authors) (2022) Genomic assessment of quarantine measures to prevent SARS-CoV-2 importation and transmission. Nature Communications, 13 (1). 1012. ISSN 2041-1723

Aggarwal, D. orcid.org/0000-0002-5938-8172, Warne, B. orcid.org/0000-0003-1326-0373, Jahun, A.S. orcid.org/0000-0002-4585-1701 et al. (725 more authors) (2022) Genomic epidemiology of SARS-CoV-2 in a UK university identifies dynamics of transmission. Nature Communications, 13 (1). 751. ISSN 2041-1723

Murphy, P., Glynn, D., Dias, S. et al. (11 more authors) (2022) Modelling approaches for histology-independent cancer drugs to inform NICE appraisals : a systematic review and decision-framework. Health Technology Assessment, 25 (76). pp. 1-228. ISSN 1366-5278

Woods, B.S., Sideris, E., Palmer, S. et al. (2 more authors) (2020) Partitioned survival and state transition models for healthcare decision making in oncology : where are we now? Value in Health, 23 (12). pp. 1613-1621. ISSN 1098-3015

Di Tanna, G.L., Porter, J.K., Lipton, R.B. et al. (5 more authors) (2019) Migraine day frequency in migraine prevention: longitudinal modelling approaches. BMC Medical Research Methodology, 19. 20. ISSN 1471-2288

Lipton, R.B., Brennan, A. orcid.org/0000-0002-1025-312X, Palmer, S. et al. (7 more authors) (2018) Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective. Journal of Medical Economics (JME), 21 (7). pp. 666-675. ISSN 1369-6998

Arce Vargas, F., Furness, A.J.S., Litchfield, K. et al. (249 more authors) (2018) Fc effector function contributes to the activity of human anti-CTLA-4 antibodies. Cancer Cell, 33 (4). 649-663.e4. ISSN 1535-6108

Bojke, L., Manca, A., Asaria, M. et al. (3 more authors) (2017) How to appropriately extrapolate costs and utilities in cost-effectiveness analysis. PharmacoEconomics, 35 (8). pp. 767-776. ISSN 1170-7690

Kearns, B. orcid.org/0000-0001-7730-668X, Rafia, R., Leaviss, J. et al. (4 more authors) (2017) The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation. BMC Health Serv Res, 17 (1). p. 78.

Brabyn, S., Araya, R., Barkham, M. et al. (16 more authors) (2016) The second Randomised Evaluation of the Effectiveness, cost-effectiveness and Acceptability of Computerised Therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trial. Health Technology Assessment, 20 (89). pp. 1-64. ISSN 1366-5278

Faria, R. orcid.org/0000-0003-3410-1435, Woods, B. orcid.org/0000-0002-7669-9415, Griffin, S. orcid.org/0000-0003-2188-8400 et al. (3 more authors) (2016) Prevention of progression to cirrhosis in hepatitis C with fibrosis:effectiveness and cost effectiveness of sequential therapy with new direct-acting anti-virals. Alimentary pharmacology & therapeutics. pp. 866-876. ISSN 1365-2036

Whyte, S., Dixon, S. orcid.org/0000-0001-7394-7009, Faria, R. et al. (4 more authors) (2016) Estimating the Cost-Effectiveness of Implementation: Is Sufficient Evidence Available? Value in Health, 19 (2). pp. 138-144. ISSN 1098-3015

Littlewood, E., Duarte, A., Hewitt, C. et al. (23 more authors) (2015) A randomised controlled trial of computerised cognitive behaviour therapy for the treatment of depression in primary care: the Randomised Evaluation of the Effectiveness and Acceptability of Computerised Therapy (REEACT) trial. HEALTH TECHNOLOGY ASSESSMENT, 19 (101). 1-+. ISSN 1366-5278

Palmer, S., Smaczynska-de Rooij, I.I., Marklew, C.J. et al. (5 more authors) (2015) A dynamin-actin interaction is required for vesicle scission during endocytosis in yeast. Current Biology, 25 (7). pp. 868-878. ISSN 0960-9822

Bartholomew, I., Nienow, P., Sole, A. et al. (4 more authors) (2011) Supraglacial forcing of subglacial drainage in the ablation zone of the Greenland ice sheet. Geophysical Research Letters, 38 (8). L08502. ISSN 0094-8276

Claxton, K. orcid.org/0000-0003-2002-4694, Palmer, S. orcid.org/0000-0002-7268-2560, Bojke, L. orcid.org/0000-0001-7921-9109 et al. (2 more authors) (2006) Priority setting for research in health care: An application of value of information analysis to glycoprotein IIb/IIIa antagonists in non-ST elevation acute coronary syndrome. International Journal of Technology Assessment in Health Care. pp. 379-387. ISSN 0266-4623

Woolacott, N., Bravo Vergel, Y., Hawkins, N. et al. (10 more authors) (2006) Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review. Clinical and Experimental Rheumatology, 24 (5). pp. 587-593. ISSN 1593-098X

Palmer, S., Sculpher, M., Philips, Z. et al. (9 more authors) (2005) Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service? International Journal of Cardiology, 100 (2). pp. 229-240. ISSN 0167-5273

Manca, A. and Palmer, S. (2005) Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials. Applied Health Economics and Health Policy, 4 (2). pp. 65-75. ISSN 1175-5652

Scott, J., Palmer, S., Payel, E. et al. (2 more authors) (2003) Use of cognitive therapy for relapse prevention in chronic depression. Cost-effectiveness study. British Journal of Psychiatry, 182 (3). pp. 221-227. ISSN 0007-1250

Creed, F., Ratcliffe, J., Fernandez, L. et al. (6 more authors) (2001) Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Annals of Internal Medicine, 134 (9 part). pp. 860-868. ISSN 0003-4819

Monograph

Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the collection patient reported outcome measures in the National Clinical Audits for assessing costeffectiveness Work Package 1. What patient reported outcome measures should be used in the 13 health conditions specified in the 2013/14 National Clinical Audit programme? APPENDIX C, INFLAMMATORY BOWEL DISEASE. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) . Policy Research Unit in Economic Evaluation of Health and Care Interventions

Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix D - Epilepsy. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (RR0031). Policy Research Unit in Economic Evaluation of Health and Care Interventions

Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix E - Diabetes. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (RR0032). Policy Research Unit in Economic Evaluation of Health and Care Interventions

Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) . Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix F - Bowel Cancer. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (RR0032). Policy Research Unit in Economic Evaluation of Health and Care Interventions

Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix G - Head and Neck Cancer. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) . Policy Research Unit in Economic Evaluation of Health and Care Interventions

Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix H - Psychological Therapies. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (RR0037). Policy Research Unit in Economic Evaluation of Health and Care Interventions

Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix I - Schizophrenia. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (RR0035). Policy Research Unit in Economic Evaluation of Health and Care Interventions

Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix J - Dementia. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (RR0037). Policy Research Unit in Economic Evaluation of Health and Care Interventions

Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Appendix K - Cardiovascular. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (RR0038). Policy Research Unit in Economic Evaluation of Health and Care Interventions

Ara, R., Duarte, A., Harnan, S. et al. (4 more authors) (2015) Supporting the routine collection of patient reported outcome measures in the National Clinical Audits for assessing cost-effectiveness. Work Package 1. What patient reported outcome measures should be used in the 2013/14 National Clinical Audit Programme. Project Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (29). Policy Research Unit in Economic Evaluation of Health and Care Interventions

Whyte, S., Dixon, S., Faria, R. et al. (3 more authors) (2014) Getting cost-effective technologies into practice: the value of implementation. An application to B-type natriuretic peptide (BNP) testing in diagnosing chronic heart failure. Report. Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) (EEPRU 025). Policy Research Unit in Economic Evaluation of Health and Care Interventions

Claxton, K. orcid.org/0000-0003-2002-4694, Palmer, S. orcid.org/0000-0002-7268-2560, Sculpher, M. orcid.org/0000-0003-3746-9913 et al. (1 more author) (2010) Appropriate perspectives for health care decisions. Discussion Paper. CHE Research Paper . Centre for Health Economics, University of York , York, UK.

Bojke, L., Claxton, K., Palmer, S. et al. (1 more author) (2006) Defining and characterising structural uncertainty in decision analytic models. Research Report. CHE Research Paper (9). Centre for Health Economics , York, UK.

This list was generated on Wed Apr 2 19:27:30 2025 BST.